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Abstract
Background: Pneumonia is a leading cause of hospitalization during Hajj and susceptibility and transmission may
be exacerbated by extreme spatial and temporal crowding. We describe the number and temporal onset, co–
morbidities, and outcomes of severe pneumonia causing critical illness among pilgrims.
Method: A cohort study of all critically ill Hajj patients, of over 40 nationalities, admitted to 15 hospitals in 2 cities
in 2009 and 2010. Demographic, clinical, and laboratory data, and variables necessary for calculation of the Acute
Physiology and Chronic Health Evaluation IV scores were collected.
Results: There were 452 patients (64.6% male) who developed critical illness. Pneumonia was the primary cause of
critical illness in 123 (27.2%) of all intensive care unit (ICU) admissions during Hajj. Pneumonia was community
(Hajj)–acquired in 66.7%, aspiration–related in 25.2%, nosocomial in 3.3%, and tuberculous in 4.9%. Pneumonia
occurred most commonly in the second week of Hajj, 95 (77.2%) occurred between days 5–15 of Hajj,
corresponding to the period of most extreme pilgrim density. Mechanical ventilation was performed in 69.1%.
Median duration of ICU stay was 4 (interquartile range [IQR] 1–8) days and duration of ventilation 4 (IQR 3–6) days.
Commonest preexisting co–morbidities included smoking (22.8%), diabetes (32.5%), and COPD (17.1%). Short–term
mortality (during the 3–week period of Hajj) was 19.5%.
Conclusion: Pneumonia is a major cause of critical illness during Hajj and occurs amidst substantial crowding and
pilgrim density. Increased efforts at prevention for at risk pilgrim prior to Hajj and further attention to spatial and
physical crowding during Hajj may attenuate this risk.
Keywords: Respiratory tract infection, Pneumonia, Hajj, Co–morbidities, APACHE IV
Background
Hajj is the largest annual pilgrimage in the world, falling
on the 12th lunar month of each year. The pilgrimage
takes, on average, 7 days, but the period of Hajj is up to
21 days Pilgrims performing Hajj must perform specific
rituals while following a specific route, i.e. performing
the rituals of Hajj in a sequence other then the correct
one will render one’s pilgrimage unsuccessful and incom-
plete, and in such cases the entire pilgrimage must be
repeated. Pilgrims move from one holy site to another
on–foot or sometimes by bus. Overcrowding, fatigue, ex-
treme temperatures (ranging 24–37°C), intravascular vol-
ume and electrolyte disturbances contribute to illness
during Hajj and may place pilgrims at increased risk for
communicable diseases. One Hajj location, Mina, is ap-
proximately 2.9 square kilometers in size, and contains
over 30,000 shared tent–type houses. These rectilinear
structures ranged in size from 4x4m through to 8x12m.
Each tent will usually be inhabited by 50 to 100 pilgrims
(Figure 1). In comparison, the approximate areas of other
set locations of housing include Makkah, at 850 (urban)
to 1200 square kilometers (metro); Arafat, 10.4 square
kilometers and Medina 589 square kilometers in area [1].
Pneumonia is a common and potentially life–threaten-
ing illness that continues to be a major global health
problem, particularly among the elderly attempting Hajj
[2]. Among infectious diseases, community acquired
pneumonia (CAP) is the leading cause of death in the
world and is associated with a substantial economic bur-
den to healthcare systems [2]. Annually, approximately
151 million new cases of pneumonia are diagnosed
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worldwide and 11 million people require hospitalization.
Treatment failure rates for pneumonia are as high as
15% [3-5]. Death rates from CAP increase with the pres-
ence of co–morbidities such as chronic heart failure,
advanced chronic obstructive pulmonary disease (COPD),
neurological diseases, cirrhosis, and advanced age [6-8].
Several studies have reported that respiratory tract
infections are the leading types of infections during Hajj
[9-11] and are a common cause of severe sepsis and
septic shock necessitating ICU admission [12]. Pulmon-
ary complications resulting from pneumonia are re-
sponsible for the second (after cardiovascular disease)
greatest number of deaths during Hajj [9,10], resulting
in a considerable burden on patients and the healthcare
system. Furthermore, novel pneumonia acquired and
spread during Hajj could lead to global outbreaks as
over 2 million pilgrims return to their countries. In this
study, we provide an account of pneumonia–related
critical illness among hospitals providing medical care
to Hajj pilgrims. We describe the number (and propor-
tion) and temporal onset of severe pneumonia, patient
characteristics, co–morbidities, severity of illness and
clinical outcomes in addition to providing an overall in-
cidence proportion for pneumonia-related critical illness
during Hajj.
Methods
Study design & site
We prospectively designed a cohort study to occur over
two consecutive Hajj years (November 18 to December
9 2009; November 7 to December 1 2010) and con-
ducted on all patients admitted to ICU for at least 4 h.
The primary outcome was the number (proportion of all
ICU patients) and temporal onset for severe pneumonia.
Secondary outcomes included patient co–morbidities,
severity of illness and clinical outcomes, in addition to
an overall incidence proportion (number of patients with
pneumonia-related critical illness divided by the number
of all Pilgrims) over the Hajj study period. Patients were
followed from ICU admission until discharge, transfer or
death, in the following centers: Al–Zahir Hospital, Mak-
kah [39 beds], Heraa Hospital, Makkah [28 beds], King
Faisal Hospital, Makkah [20 beds], Ajyad Hospital,
Makkah [12 beds], Al–Noor Specialty Hospital, Makkah
[24 beds], Al–Wadee Hospital, Mina [28 beds], Emer-
gency Hospital, Mina [28 beds], Al–Jesser Hospital, Mina
[28 beds], Al–Shareh Al–Jaded Hospital, Mina [18 beds],
Arfat General Hospital, Arafat [28 beds], Nemrah Hospital,
Arafat [12 beds], Al–Rahma Hospital, Arafat [18 beds],
King Fahd General Hospital, Al–Medina [32 beds], Al–
Ansar Hospital, Al–Medina [20 beds], and Ohoud Hos-
pital, Al–Medina [12 beds]. The 15 centers participating in
this study represent all fully functional and provisioned
Saudi ministry of health hospitals servicing pilgrim during
the study period. The hospitals in Mina and Arafat are
temporary healthcare facilities that provide medical
services only during the Hajj period while those in
Makkah and Al–Medina are permanent facilities that
provide healthcare services to patients throughout the
year. The hospitals in Mina operate for a maximum of
Figure 1 Tent housing facilities located in Mina inundated by pilgrims.
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2 weeks per year as opposed to the hospitals in Arafat
that function for only 1 week per year; the duration of
service depends mainly upon medical demand during
Hajj.
Study subjects and data collection
The acute physiology and chronic health evaluation
(APACHE) score has been used worldwide for measur-
ing ICU performance [13] and offers validated ICU risk–
adjustment models for mortality and ICU length of stay
[14,15]. Demographic, clinical, laboratory data, and vari-
ables necessary for the calculation of the APACHE IV
score (vital signs, Glasgow Coma Scale, respiratory ther-
apy variables, urine output, and laboratory data includ-
ing serum glucose, sodium, arterial blood gas values,
complete blood count, creatinine, urea, albumin and bili-
rubin), and procedures, including mechanical ventilation
were collected by data collectors affiliated with the Hajj
medicine operations of the Saudi Arabia Ministry of
Health. The source of cultures for bacterial etiologic
diagnosis of pneumonia was expectorated sputum and
bronchoalveolar lavage when sputum was not available.
Respiratory specimen analysis using real–time reverse–
transcriptase–polymerase–chain–reaction (RT–PCR) assay
was reviewed for patients with a clinical suspicion of influ-
enza (including H1N1). Immunoassays were performed
using the COBAS Influenza A test and the AMPLICOR
Respiratory Specimen Preparation Kit (Roche, Inc).
Patients were diagnosed with aspiration pneumonia at the
discretion of an infectious diseases consultant and the at-
tendant intensivist if they suffered the following: impaired
swallowing; were on tracheal or nasogastric tube; impaired
level of consciousness preceding the onset of pneumonia;
changes seen on chest x-ray compatible with aspiration.
The diagnosis of Mycobacterium tuberculosis was estab-
lished in the present study both via clinical suspicion and
later confirmed by acid-fast bacilli cultures. All Myco-
bacterium tuberculosis cases were confirmed via cul-
ture. Collected data were reviewed for completeness
and accuracy by a committee of critical care physicians
and respiratory therapists prior to database locking and
analysis. The data was gathered on a previously piloted
case report form, from ICU patient clinical files and la-
boratory results and then transcribed to a custom
designed Microsoft Access database. APACHE–pre-
dicted and actual mortality rate and length of stay were
determined for all patients. Calculation of the APACHE
IV scores was done according to the predictor variables
described by Zimmerman et al. [13] and with the aid of
an online APACHE IV calculator, available on the Mid-
dle East Critical Care Assembly website [16]. We
defined our short–term outcome as the three–week
vital outcomes for all critically ill patients.
Statistical analysis
This was primarily a descriptive study of the entire
population of Hajj patients with critical illness and pneu-
monia; therefore, sample size calculations were not con-
ducted a priori. The distribution of all variables was
examined graphically and additionally with the Shapiro–
Wilk test, to assess the normality of distribution for
gathered variables. Categorical variables are presented as
percentages and continuous variables as means (and
standard deviations, SD) or medians (and interquartile
range, IQR) as appropriate. Student’s t–test was used for
comparisons of normal distributed continuous data and
the Mann–Whitney U test and Kruskal–Wallis test were
used for comparisons of non–parametrically distributed
data. Actual and APACHE IV–predicted mortality was
compared using both Student’s t–test and the Wilcoxon
Rank Sum Score. For categorical variables, contingency
tables were analyzed with the chi–square test, or Fisher’s
exact test for small sample sizes. A P–value <0.05 was
taken as statistically significant for individual variables.
This study was approved by the research biomedical eth-
ics board of the Saudi Ministry of Health.
Results
Baseline characteristics and temporality
The study population included 452 critically ill patients
from over 40 nationalities. The mean (±SD) age was 64
±12 years and 293 (64.6%) were male. There were 123
patients who developed pneumonia-related critical illness,
accounting for 27.2% of all ICU admissions (Table 1), and
an incidence proportion of 21.5 episodes of pneumonia-
related critical illness per million pilgrims (123 episodes
per 5.73 million over two years) during the 21-day period
of Hajj. This corresponds to 62 cases of pneumonia-
related critical illness per year or a mean of 2.9 cases of
pneumonia-related critical illness per day of Hajj. Non-
pneumonia causes of admission to ICU are listed in Ap-
pendix 1. Median APACHE IV score for critically ill
patients with pneumonia at ICU admission was 81 (IQR
63–102). The etiological agents causing severe pneumonia
in the present study were identified in 73 (59.4%) patients:
gram–negative organisms were isolated in 22 (18%);
gram–positive organisms in 13 (10.6%); fungus in 2 (1.6%);
Mycobacterium tuberculosis in 6 (4.9%); and 30 (24.4%)
had influenza A (H1N1), confirmed by PCR (Table 2).
Among all cases of pneumonia, 88 (71.5%) occurred in the
second week and 95 (77.2%) occurred between days 5–15
of Hajj (Figure 2a). Temporally, the vast majority of pneu-
monia occurred in the period following heaviest pilgrim
density, among shared tenting, in Mina (Figure 2b).
Concomitant illness
Pneumonia was associated with considerable pre–existing
co–morbidities (Figure 3) and was commonly concurrent
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with an exacerbation or onset of another medical problem
– 51 patients (41.5%) had at least 2 active diagnoses, in
addition to pneumonia. Twenty–one critically ill patients
with pneumonia (17.1%) had active cardiovascular disease
on ICU admission, 7 had atrial arrhythmias, 5 congestive
heart failure, 4 ischemic changes on electrocardiograms,
and 5 had symptomatic valvular heart disease identified
via audible murmurs in the emergency triage areas and
confirmed through echocardiograms performed in ICU.
Twenty–six critically ill patients with pneumonia (21.1%)
had new or exacerbated non–infectious pulmonary dis-
eases on ICU admission: 10 with COPD exacerbations, 7
evolved to acute respiratory distress syndrome, and 9 had
severe asthmatic attacks. Thirteen critically ill patients
with pneumonia (10.6%) had neurological disorders on ad-
mission; 8 with transient ischemic attacks, 3 had metabolic
encephalopathy, and 3 had severe peripheral neuropathy.
Therapies received
A total of 85 patients (69.1%) received mechanical venti-
lation: 34 (40%) non–invasive ventilation; 31 (36.5%) as-
sist–control ventilation; 12 (14.1%) controlled ventilation;
5 patients with invasive continuous positive airway pres-
sure; and 3 were treated with high frequency oscillatory
ventilation. Median duration of mechanical ventilation
was 4 (IQR 3–6) days, with a maximum of 13 days.
Clinical outcomes
Short–term (3-week) mortality was 16.2% among all critic-
ally ill patients during Hajj, and 19.5% among all patients
with pneumonia (P=0.34). Median APACHE IV predicted
mortality for all patients was 18% (95% confidence interval
24.6–29.1%) and 29.6% (95% confidence interval 28.8–
37.6%) for patients with pneumonia. Actual (short–term)
mortality was significantly less than predicted longer–term
mortality (P=0.007). Median APACHE IV score on ICU
admission for critically ill patients with pneumonia was 78
(IQR 58.5–96) for patients who eventually survived and
102 (IQR 79.5–123.5) among patients who died
(P<0.0001). Actual mortality was highest among multidrug
resistant isolated organisms (4/12, 33%), compared to non-
resistant (0), those resistant to one type of antibiotics
(10/37, 27%), and those resistant to two types of antibio-
tics (6/21, 28.6%) (P= 0.71). Overall, of 123 patients with
pneumonia, 84 (68.3%) were discharged from the ICU to
the hospital ward without residual complications, 27
(22%) were referred to specialty centers for advanced care,
and 12 (9.6%) were discharged home, 3 of whom against
medical advice (Table 3). Length of stay in ICU at Hajj
centers was 4 (IQR 1–8) days in comparison to APACHE
IV predicted length of stay of 6.3 (IQR 5.3–7.3) days
(p=0.007); many of these patients were transported out-
side of Hajj temporary facilities during the pilgrimage.
Table 1 Demographic characteristics of 123 ICU
pneumonia patients during Hajj, 2009 and 2010
Characteristics N (%) or Median (IQR)
Age, years 64 ±12
Age group
30 – 50 23 (18.7)
51 – 60 22 (17.9)
61 – 70 47 (38.2)
71 – 80 24 (19.5)
> 80 7 (5.7)
Gender, male 79 (64.2)
Ethnicity
Black 28 (22.8)
East Asian 24 (19.5)








Values are displayed as n (%), mean ± SD.
Table 2 Isolated bacteria among patients with
pneumonia–related critical illness during Hajj, 2009 &
2010, and antibiotics sensitivity results
Microorganisms isolated in sputum culture
Microorganism Number of positive
cultures (n = 32)
Acinetobacter sp. 8 (26.7%)
Klebsiella sp. 5 (16.7%)
Pseudomonas aeruginosa 5 (16.7%)
Staphylococcus aureus 3 (10%)
MRSA 3 (10%)
Streptococcus sp. 3 (10%)
Escherichia coli 3 (10%)
Candida albicans 2 (6.7%)
Microorganisms isolated in blood cultures
Microorganism Number of positive
cultures (n = 5)
MRSA 4 (80%)
Staphylococcus aureus 1 (20%)
Antibiotic sensitivity results
Sensitive to all antibiotics 3 (4.1%)
Resistance to one class of antibiotic 37 (50.7%)
Resistance to two classes of antibiotics 21 (28.8%)
Resistance to three or more classes of antibiotics 12 (16.4%)
Values are displayed as n (%).
Abbreviations: MRSA (methicillin–resistant Staphylococcus aureus).
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Discussion
In this large cohort study of all pilgrims during two con-
secutive Hajj seasons, we found that among 452 critically
ill patients, pneumonia was the reason for admission to
ICU in 27%. Importantly, the vast majority of pneumo-
nia–related critical illness is acquired during Hajj and
temporally relates to extreme spatial crowding during
site–to–site migration and shared nighttime tenting
[17,18]. This represents a substantial burden of illness
for travelers, Saudi Arabia healthcare facilities, and po-
tentially for the healthcare jurisdictions to which pil-
grims will return.
Figure 2 a. Pneumonia-related critical illness per day over the period of Hajj and the location of pilgrims during Hajj*. *Incident cases of
pneumonia for each day represent the combined number of cases from both Hajj years. b. Combined number of ICU hospitalizations for each
day of Hajj in two consecutive Hajj seasons.
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From a public health perspective, Hajj could facilitate
dissemination of influenza or other infections around
the globe [19]. It has been estimated that more than one
in three pilgrims will experience respiratory symptoms
during their stay in Mina [20]. Recent work highlighting
the high rates of infection and carriage of influenza virus
in pilgrims returning from Mecca emphasizes the need
for international cooperation and strategies to minimize
this risk [20-22]. Hajj accommodation is, of necessity, in
tents in the desert plains of Mina, and it is not unusual
for 50–100 people to share a single tent at night [23].
Such overcrowding and continuous close contact greatly
increases the spread of respiratory infections.
Pneumonia prevention should be an increased focus of
Hajj medicine. Vaccination against seasonal and pan-
demic influenza strains in addition to Pneumococcal
vaccine should be considered for at–risk patients before
Hajj. Intra–pilgrimage frequent hand washing, and po-
tentially the wearing of face masks for patients with early
symptoms, should be a future focus of Hajj medicine in
order to reduce the burden of respiratory tract infection.
Also, improvements in pilgrim living conditions with
less spatial crowding and decreased density of pilgrims
in shelters in Mina may decrease the incidence of trans-
mission of severe pneumonia in Hajj and should be
explored further. Beyond the period of Hajj, patients
who have returned from the pilgrimage (and clinicians
evaluating them) should be vigilant for signs of
pneumonia.
Knowledge about the etiological agent of pneumonia–
related critical illness is an important but challenging
step in the management of pneumonia in such mass
gatherings [9-11]. Median length of stay for ICU pneu-
monia patients in our cohort was 4 (IQR 1–8) days. Dur-
ing this period it was practically difficult to isolate
organisms from all patients due to early initiation of
antimicrobial therapy prior to sampling, and limited cap-
acity for testing in temporary hospital laboratories. The
massive influx of patients on hospitals generally and
ICUs specifically posed significant challenges to ICU
physicians and nurses collecting more detailed data on
critically ill patients. Several studies have reported on
the occurrence of pneumonia and its etiological agents
in non–critically ill patients during Hajj. Ashgar et al.,
reported that Candida albicans (28.7%), Pseudomonas
aeruginosa (21.8%), and Legionella sp. (14.9%) were the
most frequent isolates in three hospitals during Hajj and
that Mycobacterium tuberculosis accounted for 1% of
pneumonia cases [24]. In our cohort, prevalence of tu-
berculosis was similar at 4.9%. Madani et al., reported
that pneumonia accounted for 22% of all ICU
Figure 3 Co–morbidities associated with Hajj ICU pneumonia patients. Abbreviations: CHF (congestive heart failure); CVA (cerebrovascular
accident); CAD (coronary artery disease); CRF (chronic renal failure); COPD (chronic obstructive pulmonary disease); DM (diabetes mellitus); HTN
(hypertension).
Table 3 Outcomes of Patients with pneumonia–related
critical illness during Hajj, 2009 & 2010
Outcome N (%) or Median (IQR)
Actual mortality (at 3 weeks) 24 (19.5%)
APACHE IV predicted mortality 36 (29.6%, IQR 11.1%–49.4%)
Primary Cause of Death
Primarily Infectious 8 (33.3)
Septic shock 6 (25)
Lung abscess 2 (8.3)
Pulmonary, secondary to pneumonia 14 (58.3)
Acute respiratory distress syndrome 11 (45.8)
Hypoxia or severely impaired ventilation 3 (12.5)
Cardiac arrhythmia 2 (8.3)
Values are displayed as n (%), median (IQR).
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admissions to Mina and Arafat hospitals during Hajj and
that tuberculosis accounted for 5.9% of pneumonia cases
[9]. Alzeer et al., reported that tuberculosis (20%),
Gram–negative organisms (18.8%) and Streptococcus
pneumonia (10%) were the frequent isolates from
patients admitted to two hospitals in Makkah during
Hajj, and concluded that the etiological agents of pneu-
monia during Hajj are different from those of more typ-
ical community acquired illness [11]. We recommend
that future studies focus on identifying the microbio-
logical etiology of critical illness–related pneumonia in
Hajj, which might help estimate the impact of specific
prevention and also guide empiric therapy during Hajj.
Pilgrims may be at higher risk of acquiring very trans-
missible organisms, such as respiratory viruses, certain
bacteria, and Mycobacterium tuberculosis, during Hajj.
This has significant public health implications for tuber-
culosis control in countries with large Muslim popula-
tions. The intense congestion, living in close proximity
with vast crowds and the increasing percentage of eld-
erly pilgrims, are all factors potentially magnifying this
risk. Additionally, many Muslims travel from countries
where tuberculosis is highly endemic. A recent study
conducted on Malaysian pilgrims revealed that 10% dis-
played a significant increase in immune response to
QuantiFERON tuberculosis assay antigen post–Hajj
when compared to pre–Hajj [25].
Over the past decade, several risk factors for pneu-
monia–related morbidity and mortality have been
detected [26,27]. A number of studies reported that
occurrence of pneumonia in diabetic patients was asso-
ciated with a poor prognosis [28,29]. Our study con-
firms that older ages, diabetes, smoking, chronic
conditions such as asthma and COPD and an immune
compromised state are conditions commonly associated
with pneumonia–related critical illness. The vast ma-
jority of these patients required mechanical ventilation
and some suffered severe oxygenation failure. Despite
high severity of illness by APACHE IV scores, short–
term mortality during the period of Hajj was favorable
to that predicted, highlighting that with sufficient plan-
ning and provision of advanced temporary critical care
services, severe pneumonia and respiratory failure can
be managed under challenging circumstances such as
mass gatherings. However, it is important to note that
the ultimate mortality rate among critically ill patients
in our cohort is likely to be underestimated by the
ICU mortality as some patients may have died after
transfer from ICU to the ward or to other hospitals.
Conclusion
Pneumonia is a major cause of critical illness during Hajj
and occurs amidst substantial crowding and pilgrim
density. Increased efforts at prevention for at–risk
patients prior to Hajj and further attention to spatial and
physical crowding during Hajj may attenuate this risk.
We also found that severe pneumonia during Hajj is
associated with considerable co–morbidities and these
may prove helpful in identifying patients at increased
risk prior to travel to Saudi Arabia. Future studies
should focus more heavily upon prevention, in addition
to diagnosis, etiology, and management of severe pneu-
monia during Hajj.
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Appendix 1. Non-pneumonia causes of admission to ICU
among 452 critically ill patients
*Some patients had more than one admitting diagno-
sis; hence, the total number is greater than 452 patients.
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DM: Diabetes mellitus; COPD: Chronic obstructive pulmonary disease;
ICU: Intensive care unit; CAP: Community–acquired pneumonia;
APACHE: Acute physiology and chronic health evaluation; AP: Aspiration
pneumonia; IQR: Interquartile range.
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